We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$216M
2
CPT icon
Camden Property Trust
CPT
+$180M
3
AMT icon
American Tower
AMT
+$137M
4
PLD icon
Prologis
PLD
+$122M
5
EXR icon
Extra Space Storage
EXR
+$90.4M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$181M
2
AVB icon
AvalonBay Communities
AVB
+$166M
3
HST icon
Host Hotels & Resorts
HST
+$163M
4
REG icon
Regency Centers
REG
+$134M
5
ESS icon
Essex Property Trust
ESS
+$92.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KZR
1226
DELISTED
Kezar Life Sciences
KZR
$2K ﹤0.01%
15
+6
+67% +$861
MCRB icon
1227
Seres Therapeutics
MCRB
$45M
$2K ﹤0.01%
16
– –
MGNX icon
1228
MacroGenics
MGNX
$233M
$2K ﹤0.01%
209
– –
MGTX icon
1229
MeiraGTx Holdings
MGTX
$1.08B
$2K ﹤0.01%
130
– –
MIRM icon
1230
Mirum Pharmaceuticals
MIRM
$6.56B
$2K ﹤0.01%
89
– –
MXCT icon
1231
MaxCyte
MXCT
$108M
$2K ﹤0.01%
293
– –
NAUT icon
1232
Nautilus Biotechnolgy
NAUT
$132M
$2K ﹤0.01%
362
– –
NRIX icon
1233
Nurix Therapeutics
NRIX
$2.45B
$2K ﹤0.01%
152
– –
NUVL
1234
DELISTED
Nuvalent
NUVL
$2K ﹤0.01%
125
– –
QSI icon
1235
Quantum-Si Incorporated
QSI
$153M
$2K ﹤0.01%
343
– –
RAPT
1236
DELISTED
RAPT Therapeutics
RAPT
$2K ﹤0.01%
13
– –
RLMD icon
1237
Relmada Therapeutics
RLMD
$540M
$2K ﹤0.01%
83
+52
+168% +$1.07K
RPTX
1238
DELISTED
Repare Therapeutics
RPTX
$2K ﹤0.01%
127
– –
RYTM icon
1239
Rhythm Pharmaceuticals
RYTM
$7.31B
$2K ﹤0.01%
172
– –
SRRK icon
1240
Scholar Rock
SRRK
$5.88B
$2K ﹤0.01%
118
– –
TBPH icon
1241
Theravance Biopharma
TBPH
$873M
$2K ﹤0.01%
215
– –
VNDA icon
1242
Vanda Pharmaceuticals
VNDA
$304M
$2K ﹤0.01%
191
– –
YMAB
1243
DELISTED
Y-mAbs Therapeutics
YMAB
$2K ﹤0.01%
149
– –
KLRS
1244
Kalaris Therapeutics
KLRS
$80.9M
$2K ﹤0.01%
10
– –
TVRD
1245
Tvardi Therapeutics
TVRD
$20.1M
$2K ﹤0.01%
5
– –
PETQ
1246
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99
– –
ME
1247
DELISTED
23andMe Holding Co
ME
$2K ﹤0.01%
32
+14
+78% +$1.28K
DCPH
1248
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2K ﹤0.01%
199
– –
BLU
1249
DELISTED
BELLUS Health Inc.
BLU
$2K ﹤0.01%
229
– –
RUBY
1250
DELISTED
Rubius Therapeutics, Inc
RUBY
$2K ﹤0.01%
307
– –
48 49
50
51 52

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.